Health Canada

Health Canada’s Consultation Summary

Dr. Carole Légaré from Health Canada spoke at the N2 Annual Conference and provided an overview and results from...

Register for the upcoming Good Clinical Practice virtual symposium

Health Canada is looking for your feedback by December 14, 2021

N2 is working in partnership with Health Canada (HC) on their consultation to seek input from Canadians and key...

Submit your COVID-19 related questions for Health Canada by Friday!

To make sure the questions relate to COVID-19 and not the Guide 100 or other Health Canada issues on...

Notice: Expedited Review of Health Product Submissions and Applications to address COVID-19

Date: March 18, 2020 Our file number: 20-104980-839 On March 18, 2020, the Minister of Health approved an Interim...

Drugs and medical devices recently authorized by Health Canada

As part of Health Canada's commitment to make information available to patients and the public, Health Canada recently...

U.S. FDA and Health Canada will be co-hosting a regional public consultation

May 6, 2022

The U.S. FDA and Health Canada will be co-hosting a regional public consultation on Wednesday, May...

Health Canada Changes Time for Keeping Clinical trial Records for Drugs and Natural Health Products

Mar 4, 2022

Health Canada is pleased to announce they have reduced the period for keeping clinical trial...

Health Canada’s Consultation Summary

Mar 1, 2022

Dr. Carole Légaré from Health Canada spoke at the N2 Annual Conference and provided an overview...

Opportunity to Comment on Draft (Step 2) ICH Guidance: E19 Optimization of Safety Data Collection

by Barbara Brown | Jul 8, 2019 | Health Canada, N2 News

The Draft (Step 2) ICH Guidance: E19 Optimization of Safety Data Collection was released by the International Council for Harmonisation (ICH) Assembly and is posted in English only on the ICH website for information and comment. If you wish, you may provide comments...

Next Entries »